Cardiologist with an special interest in heart failure. PhD. PCHF Zürich alumni. Uppsala University Hospital.
Joined November 2021
- Tweets 225
- Following 77
- Followers 57
- Likes 931
24 Photos and videos
Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mort... sciencedirect.com/science/ar…
19
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure | Journal of the American Heart Association ahajournals.org/doi/10.1161/…
1
27
Late gadolinium enhancement imaging and sudden cardiac death academic.oup.com/eurheartj/a…
57
Tymon Pol retweeted
6 Dec 2024
Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics. Read more in EHJ
doi.org/10.1093/eurheartj/eh…
@ESCardio @ESC_Journals #genetic #cardiomyopathies
1
10
22
2,744
Tymon Pol retweeted
3 Dec 2024
HFpEF remains a challenge: poor QoL and functional capacity. While reducing sympathetic activity, beta-blockers may worsen exercise tolerance. Evidence on outcomes is mixed, especially in HFpEF AF. We need RCTs! Read now in #HREV (link.springer.com/article/10…). @ParagGoyalMD
3
9
1,125
Natural Course of Electrocardiographic Features in Arrhythmogenic Right Ventricular Cardiomyopathy and Their Relation to Ventricular Arrhythmic Events | Journal of the American Heart Association ahajournals.org/doi/full/10.…
1
48
SPIRRIT-HFpEF - study design:
- First R-RCT in heart failure
- HF w/ LVEF ≥40%
- Open label spironolactone/eplerenone vs. usual care
- ~2,400 pts
- Primary outcome: CV death total HHF
- Results expected 2026/27
onlinelibrary.wiley.com/doi/…
1
1
133
The trials I'm looking forward to the most at #ESC2024:
FINEARTS - First MRA trial to show benefit on hard endpoints (CV death total HF) in pts HF w/ LVEF >40%
HELIOS-B - Vutrisiran in pts w/ ATTR (wt h). Primary EP met (all cause☠️ CV events) w/ effect on top of Tafamidis
1
219
Tymon Pol retweeted
23 Aug 2024
A must-read for all cardiologists: the Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies is now out 🔥🔥🔥
sciencedirect.com/science/ar…
4
153
378
48,220
Always ask why: should genetic testing be routinely offered to all pts w/ unexplained cardiac conduction disorders with pacemaker <60yrs ? Interesting paper, worth a read👇
14 Jul 2024
Should patients with cardiac conduction disorders (CCD) be genetically tested? Which 🧬 should be analyzed? What is the contribution of each 🧬?
Come with me to see the results of our new study published this week @JACCJournals 👇 Long 🧵 (2/16)
2
78
Tymon Pol retweeted
24 Jun 2024
🚨🚨🚨 MAJOR news in the #amyloidosis world this morning with positive topline results of #HELIOS-B. #Vutrisiran met all primary & secondary endpoints. Let's break down what we know... #StanfordAmyloidCenter (1/13)
3
59
168
27,042
Tymon Pol retweeted
21 Jun 2024
Register now for the Updates in Heart Failure. Engage, learn, & connect with global peers in heart failure management! Join us in Stockholm, Sweden, on 16-17th December 2024.
#HeartFailureCongress #Medical#Cardiology
3
2
248
Word class update with fantastic faculty and fascinating discussions - highly recommended!
2
67
Sound arguments - totally agree.
18 May 2024
I will start another debate on left atrial appendage occlusion. This one in Hyde Park format at #HRS2024
I have 9 reasons why I am not convinced this procedure benefits patients. This is percutaneous closure. Surgical closure was shown effective (along with AC) in LAAOS3
1/
2
141
Presented today at #ACC24:
In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
ALT Time-to-event curves for death from any cause at 180 days
4
313
611
322,272
SGLT2i in ACHD
👉 Retrospective data from 174 pts
👉Safety in ACHD population confirmed
👉HF-hosp 3-fold lower in SGLT2i treated pts
jacc.org/doi/10.1016/j.jacc.…
1
76
LGE distribution patterns in dilated cardiomyopathy: genotype–phenotype correlation academic.oup.com/ehjcimaging…
1
4
203
Great document that provide guidance on genetic cardiomyopathies 👇
sciencedirect.com/science/ar…
5
181